# A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

> clinical trial · VERIFIED · 2026-06-12

Status: RECRUITING · Sponsor: Takeda · Condition: Immune Thrombocytopenic Purpura (ITP)

- Company: Takeda
- Sector: hematology
- Primary source: https://clinicaltrials.gov/study/NCT06722235

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.